IPR rules and issues in relation to the Korean market – is patenting different in Korea, compared to Europe and USA?
Yes – there are differences in legislation and practices in addition to cultural differences, which together may lead to a different outcome in the patent application process in Korea compared to Europe or America. We will discuss the main differences and give examples of how to take the Korean practice into account already when writing the first patent application as well as in the subsequent prosecution by the Korean Authorities in order to increase the probability of a patent approval.
To start off the seminar Life Science Ambassador Thomas Jonsson will provide an overview of the Korean medical market which now has become the 4th biggest in Asia and 15th in the world. He will cover a range of topics from who are the major companies, entry strategies, innovation, the aging population, cluster formations, to regulatory and pricing issues.
4 September 2012
Meeting room Stavanger at Arne Jacobsens Allé 15, 2300 Copenhagen S, Denmark.
| In collaboration with|
|08:00-08:30||Registration, networking and breakfast|
|08:35-09.10||The Korean medical market right now|
Thomas Jonsson, Medicon Valley Life Science Ambassador in South Korean and Japan
|09:10-09:45||IPR rules and issues in relation to the Korean market|
Susanne Høiberg, European Patent & Trademark Attorney, MD, CEO and Partner at Høiberg
Good Morning Meetings are open for members and non-members of Medicon Valley Alliance.
MVA members: Free of charge (late cancellation/no-show fee DKK 500 ex VAT).
Non-members: DKK 2.000 ex VAT will be invoiced prior to the meeting.
Become a member of MVA here.
Registration for this event has closed.